US$ 22.01
tirzepatide news november 2025 FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide vs Semaglutide: 2025 NEJM
Description
MASH is a more severe form of the liver disease MASLD, or metabolic dysfunction-associated steatotic liver disease

It can be managed by drinking plenty of water, eating small meals, and avoiding heavy or greasy foods that might trigger discomfort

My deep-dive into what oncology nurses need to know about GLP-1 use among patients with breast cancer and survivors is now live

The product will be manufactured by Boehringer-Ingelheim for Quallent Pharmaceuticals, which is a wholly owned Express Scripts subsidiary

Can brands pivot to emotional scaffolding, lifestyle content or long-term maintenance support